References
- Choi S. -I., Brahn E.. Rheumatoid arthritis therapy: Advances from bench to bedside. Autoimmunity. 2010; 43:478–492.
- Abe T., Takeuchi T.. Rheumatoid arthritis and tumor necrosis factor α. Autoimmunity. 2001; 34:291–303.
- Kotenko S. V., Gallagher G., Baurin V. V., . IFN-ls mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol.. 2003; 4:69–77.
- Sheppard P., Kindsvogel W., Xu W., . IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol.. 2003; 4:63–68.
- Dumoutier L., Tounsi A., Michiels T., . Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-λ1: similarities with type I interferon signaling. J. Biol. Chem.. 2004; 279:32269–32274.
- Onoguchi K., Yoneyama M., Takemura A., . Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem.. 2007; 282:7576–7581.
- Pekarek V., Srinivas S., Eskdale J., . Interferon λ-1 (IFN-λ1/IL-29) induces ELR-CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-γ-independent manner. Genes Immun.. 2007; 8:177–180.
- Maher S. G., Sheikh F., Scarzello A. J., . IFN-α and IFN-λ differ in their antiproliferative effects and duration of JAK/STAT signaling activity. Cancer Biol. Ther.. 2008; 7:1109–1115.
- Marcello T., Grakoui A., Barba-Spaeth G., . Interferons α and λ inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology. 2006; 131:1887–1898.
- Hong S. H., Cho O., Kim K., . Effect of interferon-λ on replication of hepatitis B virus in human hepatoma cells. Virus Res.. 2007; 126:245–249.
- Hou W., Wang X., Ye L., . λ-interferon inhibits human immunodeficiency virus type 1 infection of macrophages. J. Virol.. 2009; 83:3834–3842.
- Jordan W. J., Eskdale J., Srinivas S., . Human interferon λ-1 (IFN-λ1/IL-29) modulates the Th1/Th2 response. Genes Immun.. 2007; 8:254–261.
- Srinivas S., Dai J., Eskdale J., . Interferon-λ1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro. Immunology. 2008; 125:492–502.
- Sack U., Kinne R. W., Marx T., . Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis. Rheumatol. Int.. 1993; 13:45–51.
- Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S., Medsger T. A., Mitchell D. M., Neustadt D. H., Pinals R. S., Schaller J. G., Sharp J. T., Wilder R. L., Hunder G. G.. The American Rheumatism Association 1987 revisedcriteria for the classification of rheumatoid arthritis. Arthritis Rheum.. 1988; 31:315–324.
- Horwood N.. Lymphocyte-derived cytokines in inflammatory arthritis. Autoimmunity. 2008; 41:230–238.
- Schett G.. Immune cells and mediators of inflammatory arthritis. Autoimmunity. 2008; 41:224–229.
- Zhou X., Kong N., Zou H., . Therapeutic potential of TGFβ-induced CD4+Foxp3+ regulatory T cells in autoimmune diseases. Autoimmunity. 2011; 44:43–50.
- Jordan W. J., Eskdale J., Boniotto M., . Modulation of the human cytokine response by interferon λ-1 (IFN-λ1/IL-29). Genes Immun.. 2007; 8:13–20.